As I hope it is." Psychiatrists and their patients are suddenly living in a moment that, five or 10 years down the line, could be considered an extraordinary inflection point. There's been no ...

Main Line Health said Friday it is working with Crozer Health to bring its obstetrics and gynecology clinicians and patients over to the Radnor health system, which operates Riddle Hospital in ...

BMS’ combination reduced the risk of cancer progression or death by 79% compared to chemotherapy in first-line patients. Median progression-free survival (PFS) was not reached in the Opdivo/Yervoy arm ...

their families and health-care providers are benefiting from the most possible and the best use of resources directed to front-line patient care," she said in a news release. The ministry said ...

"I would say that, being a physician, I understood 90% of what it was like to be a patient," Mukkamala said. "But then to all of a sudden become a patient ... was an amazing opportunity." ...

In the second-line setting, pemetrexed improves survival in nonsquamous NSCLC compared with docetaxel, and erlotinib has shown a survival benefit compared with best supportive care in patients who ...

Bristol Myers Squibb, announced that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment of adult and pediatric patients (12 years ...

OPDIVO ® (nivolumab), in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adult patients with unresectable advanced or ...

Top-line data from the SERENA-6 trial showed that camizestrant reduced the risk of disease progression or death compared to the standard-of-care regimen in previously untreated patients with HR ...

And it also pertains to how reimbursement works in dialysis access centers right now because dialysis centers are graded by CMS by how many catheter patients they have. And the fewer catheter ...

non-recurrent H3 K27M-mutant diffuse glioma patients following radiation treatment, potentially extending its use into the first-line setting. Transaction Details Jazz's tender offer for all ...